Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2. The study record itself remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T15:43:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T16:32:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision identifier in the footer of the ClinicalTrials.gov 403 Forbidden page changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T20:38:37.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T03:47:18.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page. A large portion of the Study Documents and related metadata, including document names, contributors, and source information, was removed from the listing.
    Difference
    18%
    Check dated 2026-09-21T22:46:41.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The study details page history shows a new revision entry v3.6.6 added and the prior revision v3.6.5 removed. This indicates a minor update to the page metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-31T17:12:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.